Product Information

TEMOZOLOMIDE 5 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.9313 per EA under NDC 47335089072. Its NADAC has been published 61 times since Jun 18, 2025.

FDA first approved this application on Feb 12, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for TEMOZOLOMIDE 5 MG CAPSULE has been published 61 times since Jun 18, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.